Document is current
Any future updates will be listed below
-
Authors
Noble, Kristen N.
Schley, Katharina
Abramovitz, Lisa
Willis, Sarah J.
Hayford, Kyla
Moisi, Jennifer C.
Weycker, Derek https://orcid.org/0000-0002-5405-2215
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 10 July 2025
Accepted: 7 November 2025
First Online: 27 November 2025
Declarations
:
: Lisa Abramovitz and Derek Weycker are employees of Avalere Health, which received funding from Pfizer in connection with the development of this manuscript and this study. Jennifer C. Moisi, Katharina Schley, and Sarah J. Willis are employed by Pfizer and may hold stock/stock options in Pfizer Inc. Kristen N. Noble is employed by Indiana University Health and received funding for this research from Pfizer.
: The study database was deidentified prior to its release to study investigators, as set forth in the corresponding Data Use Agreement. Use of the study database for health services research was fully compliant with the Health Insurance Portability and Accountability Act Privacy Rule and federal guidance on Public Welfare and the Protection of Human Subjects (45 CFR 46ยง46.101). Institutional review board approval was not required.
